Researchers of the Josep Carreras Leukemia Research Institute discover that a leukemic cell is capable of transforming into a non-cancerous cell through epigenetic changes.
► The Josep Carreras Foundation and the Leo Messi Foundation sign a collaboration agreement to promote research into childhood leukaemia.
► "No child with leukaemia"is the name of the research project with which this collaboration is being launched. It will study a kind of rare childhood leukaemia that has a very poor prognosis.
"The better a process is understood, the better it can be controlled. Accessibility of blood has given us a rich understanding of leukemias".
"Leukaemia will be cured. Help us decide when". With this direct and forceful motto we present today the new awareness campaign of the Josep Carreras Leukaemia Foundation.
A Josep Carreras Institute research team reveals the effectiveness of a new treatment for acute lymphoblastic leukaemia
• A Josep Carreras Leukaemia Research Institute (IJC) acute lymphoblastic leukaemia (ALL) research team, led by Dr. Josep Maria Ribera, has participated in a study published in the prestigious journal, The New England Journal of Medicine.
• The study shows that treatment with blinatumomab significantly prolongs the life expectancy of adult patients with certain kinds of leukaemia, in comparison with standard treatment with chemotherapy.
• This discovery is an important step forward for improving the prognosis for adult ALL patients, a kind of leukaemia with an incidence of 30 new cases per million every year in Spain.